PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32642794-0	2020	Regulation of GSK3beta/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer.	erastin	56-63	glycogen synthase kinase 3 alpha	Homo sapiens	14-22	
32642794-6	2020	Enhanced erastin-induced ferroptosis by overexpression of GSK-3beta was blocked by activating Nrf2.	erastin	9-16	glycogen synthase kinase 3 alpha	Homo sapiens	58-67	
32642794-7	2020	We further confirmed that overexpression of GSK-3beta strengthened erastin-induced tumor growth inhibition in breast cancer xenograft models in vivo.	erastin	67-74	glycogen synthase kinase 3 alpha	Homo sapiens	44-53	
32642794-8	2020	In summary, our findings conclude that modulation the balance between GSK-3beta/Nrf2 is a promising therapeutic approach and probably will be important targets to enhance the effect of erastin-induced ferroptosis in breast cancer.	erastin	185-192	glycogen synthase kinase 3 alpha	Homo sapiens	70-79